MEK MUTATION
Clinical trials for MEK MUTATION explained in plain language.
Never miss a new study
Get alerted when new MEK MUTATION trials appear
Sign up with your email to follow new studies for MEK MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Hope cancer drug offered to desperate patients
Disease control AVAILABLEThis program provides access to an investigational drug called ulixertinib for patients with advanced cancers that have specific genetic changes (MAPK pathway mutations). It is for people who have run out of other treatment options. The drug aims to control the cancer's growth, e…
Matched conditions: MEK MUTATION
Sponsor: xCures • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Experimental pill targets Hard-to-Treat cancers in groundbreaking trial
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called NST-628 for adults with advanced solid tumors that have specific genetic changes in a key cancer growth pathway. The study aims to find a safe and effective dose and see if the drug can shrink tumors in patients who h…
Matched conditions: MEK MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC